ochratoxin a has been researched along with acetaminophen in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brackhagen, L; Cramer, B; Degen, GH; Friebel, A; Ghallab, A; González, D; Hassan, R; Hengstler, JG; Hobloss, Z; Hoehme, S; Humpf, HU; Marchan, R; Myllys, M; Seddek, AL | 1 |
1 other study(ies) available for ochratoxin a and acetaminophen
| Article | Year |
|---|---|
Inhibition of cytochrome P450 enhances the nephro- and hepatotoxicity of ochratoxin A.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Lipocalin-2; Liver Diseases; Mice; Mycotoxins | 2022 |